“Safer supply” alternatives to toxic unregulated drug markets

The evidence for safer supply is not perfect, but in countries where deaths are escalating due to toxic unregulated drug supplies, governments need to take urgent action. This means taking calculated risks in collaboration with affected populations and investing in safer supply interventions supported by a growing observational evidence base.